Eija Nissila

University of Helsinki

Finland

Research Interests

Explore related searches

Professors in Finland Professors in Microbiology Microbiology professors in Finland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (7)

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Collaborators (13)

Matti Javanainen

University of Helsinki

FINLAND

View details

Markku Varjosalo

University of Helsinki

FINLAND

View details

Tommi Kajander

University of Helsinki

FINLAND

View details

Anne Salonen

University of Helsinki

FINLAND

View details

Oommen P Oommen

University of Tampere

FINLAND

View details

Leo Starck

University of Helsinki

FINLAND

View details

Karita Haapasalo

University of Helsinki

FINLAND

View details

Kari Salokas

University of Helsinki

FINLAND

View details

Pavel Uvarov

University of Helsinki

FINLAND

View details

Salla Keskitalo

University of Helsinki

FINLAND

View details

Martina Lorey

University of Helsinki

FINLAND

View details

Taina Sipponen

University of Helsinki

FINLAND

View details

Schahzad Saqib

University of Helsinki

FINLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Eija Nissila

Research Interests

Explore related searches

Contact this professor

Articles (7)

The COVID-19 vaccine ChAdOx1 is opsonized by anti-vector antibodies that activate complement and promote viral vector phagocytosis

The total gut mucosal and fecal bacterial load increases in successful treatment of inflammatory bowel disease with infliximab

Loss of CFHR5 function reduces the risk for age-related macular degeneration

Reduced binding of apoE4 to complement factor H promotes amyloid-beta oligomerization and neuroinflammation

Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor alpha Antagonist Infliximab in Pediatric Inflammatory Bowel Disease

Streptococcus pneumoniae pneumolysin and neuraminidase A convert high density lipoproteins into pro-atherogenic particles

Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease

Collaborators (13)

Matti Javanainen

Markku Varjosalo

Tommi Kajander

Anne Salonen

Oommen P Oommen

Leo Starck

Karita Haapasalo

Kari Salokas

Pavel Uvarov

Salla Keskitalo

Martina Lorey

Taina Sipponen

Schahzad Saqib

Make your next move.